Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Blood|July 31, 2010
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cellsClaudia Cocco, Sara Canale, Chiara Frasson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 14, 2013
Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastomaEmma Di Carlo, Paola Bocca, Laura Emionite, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunogenicity of human neuroblastomaIgnazia Prigione, Maria Valeria Corrias, Irma Airoldi, et al.
Neurobiology of Disease|October 4, 2011
In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteinsEleonora Di Zanni, Tiziana Bachetti, Sara Parodi, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 7, 2012
The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2BSara Parodi, Eleonora Di Zanni, Simona Di Lascio, et al.
Experimental Cell Research|May 18, 2010
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulationTiziana Bachetti, Eleonora Di Zanni, Pietro Balbi, et al.
Microbes and Infection|December 6, 2005
T cell mediated immune responses to Toxoplasma gondii in pregnant women with primary toxoplasmosisIgnazia Prigione, Sabrina Chiesa, Paola Taverna, et al.
Molecular Medicine (Cambridge, Mass.)|May 19, 2026
PHOX2B defects alter protein folding, cell-cycle, and mitochondrial pathways in an in vitro model of CCHSChiara Africano, Tiziana Bachetti, Eleonora Di Zanni, et al.
Pharmacological Reports : PR|March 31, 2016
Potentiation of cisplatin-induced antiproliferative and apoptotic activities by the antiarrhythmic drug procainamide hydrochlorideMaurizio Viale, Carla Fenoglio, Daniela de Totero, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastomaLizzia Raffaghello, Ignazia Prigione, Irma Airoldi, et al.
Pageof 6